CGRP(2) receptor in the internal anal sphincter of the rat: implications for CGRP receptor classification
- PMID: 10807687
- PMCID: PMC1572075
- DOI: 10.1038/sj.bjp.0703315
CGRP(2) receptor in the internal anal sphincter of the rat: implications for CGRP receptor classification
Abstract
The CGRP receptor mediating relaxation of the rat internal anal sphincter (IAS) has been characterized using CGRP analogues, homologues, the antagonist CGRP(8 - 37) and its analogues. In isolated IAS strips, the spontaneously developed tone was concentration-dependently relaxed by halpha CGRP, hbeta CGRP and rat beta CGRP (pEC(50) 8.1+/-0.2, 8.3+/-0.1 and 8.4+/-0.2, respectively; 100% maximum response). Vasoactive intestinal polypeptide (VIP) was around 7 fold more potent than halpha CGRP (pEC(50) 9.0+/-0.1; 100% maximum relaxation). [Cys(ACM(2.7))] halpha CGRP and salmon calcitonin were inactive (up to 10(-5) M). Halpha CGRP(8 - 37) (10(-5) M) antagonized responses to halpha CGRP (apparent pK(B) 5.7+/-0.3) and rat beta CGRP (apparent pK(B) 5.8+/-0.2), but not to VIP. Hbeta CGRP(8 - 37) (10(-5) M) was an antagonist against halpha CGRP (apparent pK(B) 6.1+/-0.1). Halpha CGRP(8 - 37) analogues (10(-5) M), with substitutions at the N-terminus by either glycine(8) or des-NH(2) valine(8) or proline(8), antagonized halpha CGRP responses with similar affinities (apparent pK(B) 5.8+/-0.1, 5.8+/-0.1 and 5.5+/-0.1, respectively). Peptidase inhibitors (amastatin, bestatin, captopril, phosphoramidon and thiorphan, 10(-6) M each) did not increase the agonist potency of either halpha CGRP or [Cys(ACM(2,7))] halpha CGRP, or the antagonist affinity of halpha CGRP(8 - 37) against halpha CGRP or rat beta CGRP. These data demonstrate for the first time a CGRP receptor in the rat IAS for which halpha CGRP (8 - 37) and its analogues have an affinity that is consistent with a CGRP(2) receptor. However, there is a marked species difference as the antagonist has a 100 fold lower affinity in the rat than in the same tissue of the opossum (Chakder & Rattan, 1991).
Figures





Similar articles
-
Pharmacological characterization of CGRP receptors mediating relaxation of the rat pulmonary artery and inhibition of twitch responses of the rat vas deferens.Br J Pharmacol. 1998 Apr;123(8):1673-83. doi: 10.1038/sj.bjp.0701783. Br J Pharmacol. 1998. PMID: 9605575 Free PMC article.
-
Conformational restraints revealing bioactive beta-bend structures for halpha CGRP8-37 at the CGRP2 receptor of the rat prostatic vas deferens.Br J Pharmacol. 1999 Mar;126(5):1163-70. doi: 10.1038/sj.bjp.0702432. Br J Pharmacol. 1999. PMID: 10205004 Free PMC article.
-
Bioactive beta-bend structures for the antagonist halpha CGRP(8 - 37) at the CGRP(1) receptor of the rat pulmonary artery.Br J Pharmacol. 2000 Mar;129(5):1049-55. doi: 10.1038/sj.bjp.0703152. Br J Pharmacol. 2000. PMID: 10696108 Free PMC article.
-
[Tyr0]-calcitonin gene-related peptide 28-37 (rat) as a putative antagonist of calcitonin gene-related peptide responses on opossum internal anal sphincter smooth muscle.J Pharmacol Exp Ther. 1990 Apr;253(1):200-6. J Pharmacol Exp Ther. 1990. PMID: 2329508
-
Antagonism of calcitonin gene-related peptide (CGRP) by human CGRP-(8-37): role of CGRP in internal anal sphincter relaxation.J Pharmacol Exp Ther. 1991 Mar;256(3):1019-24. J Pharmacol Exp Ther. 1991. PMID: 2005569
Cited by
-
The effect of topical anal captopril on resting anal pressure in healthy volunteers: the first human pilot study.Tech Coloproctol. 2014 Jan;18(1):39-43. doi: 10.1007/s10151-013-0986-y. Epub 2013 Feb 22. Tech Coloproctol. 2014. PMID: 23435971
-
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond.Physiol Rev. 2023 Apr 1;103(2):1565-1644. doi: 10.1152/physrev.00059.2021. Epub 2022 Dec 1. Physiol Rev. 2023. PMID: 36454715 Free PMC article. Review.
-
RAMP1 Protects Hepatocytes against Ischemia-reperfusion Injury by Inhibiting the ERK/YAP Pathway.J Clin Transl Hepatol. 2024 Apr 28;12(4):357-370. doi: 10.14218/JCTH.2023.00339. Epub 2024 Feb 29. J Clin Transl Hepatol. 2024. PMID: 38638379 Free PMC article.
References
-
- AIYAR N., RAND K., ELSHOURBAGY N.A., ZENG Z., ADAMOU J.E., BERGSMA D.J., LI Y. A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J. Biol. Chem. 1996;271:11325–11329. - PubMed
-
- CHAKDER S., RATTAN S. [Tyr°]-calcitonin gene-related peptide 28-37 (rat) as a putative antagonist of calcitonin gene-related peptide responses on opossum internal anal sphincter smooth muscle. J. Pharmacol. Exp. Ther. 1990;256:200–206. - PubMed
-
- CHAKDER S., RATTAN S. Antagonism of calcitonin gene-related peptide (CGRP) by human CGRP-(8-37): Role of CGRP in internal anal sphincter relaxation. J. Pharmacol. Exp. Ther. 1991;256:1019–1024. - PubMed
-
- CHATELAIN C., POCHON N., LACROIX J.S. Functional effects of phosphoramidon and captopril on exogenous neuropeptides in human nasal mucosa. Eur. Arch. Otorhinolaryngol. 1995;252:83–85. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous